# The Effects of Intravitreal Ozurdex Implant in DME

> **NCT03475407** · PHASE4 · UNKNOWN · sponsor: **Nune Eye Hospital, Seoul, Korea** · enrollment: 20 (estimated)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **DRUG:** Ozurdex intravitreal injection

## Key facts

- **NCT ID:** NCT03475407
- **Lead sponsor:** Nune Eye Hospital, Seoul, Korea
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-03
- **Primary completion:** 2018-06
- **Final completion:** 2018-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2018-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03475407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03475407, "The Effects of Intravitreal Ozurdex Implant in DME". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03475407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*